Lowell Blake & Associates’s Merck MRK Stock Holding History

Lowell Blake & Associates’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-3,283	Closed	-$285K	–	53
2019 Q4	$285K	Buy	+3,283	New	+$270K	0.32%	45

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Lowell Blake & Associates's MRK Position: Q1 2020 in Review

Lowell Blake & Associates sold out of Merck (MRK) in Q1 2020, closing a stake of 3,283 shares — an estimated $285K sold.

Lowell Blake & Associates first reported a position in MRK in Q4 2019 and held it in 1 quarter. The position peaked at $285K in Q4 2019. 2,477 funds tracked by Wall St. Rank hold MRK as of Q1 2020.

Lowell Blake & Associates reported no remaining Merck position as of Q1 2020 after selling out during the quarter.
Lowell Blake & Associates sold 3,283 Merck shares in Q1 2020, an estimated $285K.
Lowell Blake & Associates first reported a position in Merck in Q4 2019 and held it in 1 quarter.
Lowell Blake & Associates's Merck position peaked at $285K in Q4 2019.
2,477 funds tracked by Wall St. Rank held Merck as of Q1 2020.

Based on Lowell Blake & Associates's 13F filing for Q1 2020, filed 1 Jul 2020.